Calithera Biosciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | 0.00% | -20.32% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 97.45K | |
+26.47% | 664B | |
+25.51% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.64% | 199B | |
-10.27% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- CALA Stock
- News Calithera Biosciences, Inc.
- Calithera Biosciences, Inc. Auditor Raises 'Going Concern' Doubt